TrialCardiovascular diabetology2018

Liraglutide suppresses non-esterified free fatty acids and soluble vascular cell adhesion molecule-1 compared with metformin in patients with recent-onset type 2 diabetes.

Xiao-Min Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.